Update on the Management of Uveitic Macular Edema

Volume: 10, Issue: 18, Pages: 4133 - 4133
Published: Sep 14, 2021
Abstract
Uveitic macular edema (ME) is a frequent complication in 8.3% of uveitis patients and is a leading cause of serious visual impairment in about 40% of cases. Despite the numerous available drugs for its treatment, at least a third of patients fail to achieve satisfactory improvement in visual acuity. First-line drugs are steroids administered by various routes, but drug intolerance or ineffectiveness occur frequently, requiring the addition of...
Paper Details
Title
Update on the Management of Uveitic Macular Edema
Published Date
Sep 14, 2021
Volume
10
Issue
18
Pages
4133 - 4133
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.